Making Daily Headlines · Page 10
Moderna's Revenue Forecast Gets a Booster From Its Newer Vaccines
· New York time
Moderna raised its 2026 revenue outlook to growth of 15% to 25%, up from previous guidance of up to 10%. Its CEO said newer vaccines are gaining traction. The revised range gives investors a different assessment of the company's expected year, though it remains a forecast rather than a reported final result. A higher outlook is welcome news for a company seeking demand beyond its earlier products. The numbers have improved on the presentation slide; the actual revenue still has to arrive before the year can be totaled.
Read this story in the full newspaper →Satire. Not factual reporting. Read the original reporting from the linked publishers.